Table 2

Tumor-suppressor genes epigenetically inactivated in other cancers that were up-regulated by Bmi-1 knockdown in L428 cells

Gene symbolGene IDFold change after Bmi-1 knockdownGene title/description
    DLC1 NM024767 2.0 Deleted in liver cancer 1 
    ATM BG623786 2.3 Ataxia telangiectasia mutated gene 
    CASP8 A1830471 2.5 Caspase 8, apoptosis-related cysteine peptidase 
    ID4 U16153 2.4 Inhibitor of DNA-binding 4, dominant-negative helix-loop-helix protein 
    IGSF4 AU146373 4.6 Immunoglobulin superfamily, member 4/TSLC1 
    TUSC3 A1760262 4.6 Tumor-suppressor candidate 3 
    GLIPR1 AK024153 5.2 GLI pathogenesis related-1 
    FAM45A AK025354 6.06 Family with sequence similarity 45, member A 
    SERPINB5 NM002639 7.5 Serpin peptidase inhibitor, clade B (ovalbumin), member 5 
    LOX BE503425 21.1 Lysyl oxidase 
    ST18 BC025662 29.8 Suppression of tumorigenicity 18 
    MEG3 BC036602 36.7 Maternally expressed 3 
Gene symbolGene IDFold change after Bmi-1 knockdownGene title/description
    DLC1 NM024767 2.0 Deleted in liver cancer 1 
    ATM BG623786 2.3 Ataxia telangiectasia mutated gene 
    CASP8 A1830471 2.5 Caspase 8, apoptosis-related cysteine peptidase 
    ID4 U16153 2.4 Inhibitor of DNA-binding 4, dominant-negative helix-loop-helix protein 
    IGSF4 AU146373 4.6 Immunoglobulin superfamily, member 4/TSLC1 
    TUSC3 A1760262 4.6 Tumor-suppressor candidate 3 
    GLIPR1 AK024153 5.2 GLI pathogenesis related-1 
    FAM45A AK025354 6.06 Family with sequence similarity 45, member A 
    SERPINB5 NM002639 7.5 Serpin peptidase inhibitor, clade B (ovalbumin), member 5 
    LOX BE503425 21.1 Lysyl oxidase 
    ST18 BC025662 29.8 Suppression of tumorigenicity 18 
    MEG3 BC036602 36.7 Maternally expressed 3 
Close Modal

or Create an Account

Close Modal
Close Modal